ARTICLE | Company News

Axovant falls as CEO, president depart

February 13, 2018 1:03 AM UTC

Axovant Sciences Ltd. (NASDAQ:AXON) fell $0.38 (20%) to $1.54 on Monday after it shuffled its management team and board of directors. The neurology company said David Hung resigned as CEO and a director to pursue other opportunities. President and COO Marion McCourt also resigned as did board members Kate Falberg, Tony Vernon and Patrick Machado.

Hung, who will continue to serve as an advisor to the Roivant Sciences GmbH (Basel, Switzerland) family of companies, is succeeded by Pavan Cheruvu, a member of Roivant’s executive leadership team. Roivant is Axovant's majority owner...